Join
Live feed
·
PRReleasevia Quantisnow
Pfizer Inc. logo

FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

ByQuantisnow·Wall Street's wire, on your screen.
PFE· Pfizer Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PFE (Pfizer Inc.) and more on Quantisnow.